World AIDS Day COVID and cure chat
The COVID pandemic has touched everyone, including people living with HIV. Co-founder of The Institute of Many, Nic Dorward, spoke
vaccine
How broadly neutralising antibodies are driving the quest for an HIV vaccine
Most vaccines work by triggering the immune system to make antibodies that can protect against (or neutralise) infection. Vaccination typically
Reports of UK HIV cure are misleading
The international media have been at it again this week, with claims of an HIV cure thrown around in a
AIDS 2016: hopes high in search for vaccine
Current and forthcoming studies of vaccines to prevent HIV infection have created a new optimism that the long and challenging
RV144 paving the way for future treatments
A new scientific study conducted by a team of leading AIDS scientists reveal results that lead the way to the
Studies on three continents could have broad implications for HIV prevention research
Enrolment has begun in the first of two multinational clinical trials of an intravenously delivered investigational antibody for preventing HIV
“Shock and kill” strategy reduces virus reservoir during treatment
Researchers have revealed the final results of the REDUC Part B clinical trial to reduce the HIV reservoir in a
Are artificial antibodies the secret to getting rid of HIV?
The only functional treatment for HIV, antiretrovirals keep the amount of HIV in the body at a low level. They
Government funds ground-breaking research
A Royal Perth Hospital immunologist investigating the possibility of using an antibody to trigger natural immune responses to fight HIV
Broadly neutralizing antibody 8ANC195 recognises closed and open states of HIV-1 Env
Highlights •3.58 Å structure of 8ANC195-Env trimer defines the gp120-gp41 site of HIV vulnerability •EM structure shows 8ANC195 binds Env trimer